Crane Company (CR) Stock Analysis

64.0/100
Hold ✓ Halal Industrials
Price $206.33
Market Cap $12.33B
52-Week Change +6.20%

Is CR a good investment?

Crane Company (CR) has a Plutrex AI rating of 64.0/100 as of August 20, 2026, indicating a Hold consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Operating margin of 35.46% is 120.8% above the industrial machinery industry average of 16.07% — a structurally superior business model confirmed by gross margin of 41.74% (+13.8% vs. peers) and net margin of 12.97% (+39.3% vs. peers), representing durable competitive differentiation that is extremely difficult to replicate. Main concern: PEG ratio of 1.99x remains 17.8% above the industry average of 1.69x — investors still pay a growth-adjusted premium for a company whose forward EPS growth of 11.61% (next year) trails the industry average of 15.65% by 25.8%; the valuation concern has EASED but is NOT RESOLVED at $208.96.

Investment Summary

Crane Co. (CR) is a high-quality industrial compounder trading at $208.96 — down 6.3% from my prior report at $222.93 — which has meaningfully improved the entry setup but not yet fully resolved the valuation concern. The stock now trades at a P/E of 36.46x (down from 38.9x) and PEG of 1.99x (down from 2.12x), still above the industry average PEG of 1.69x. The business quality is exceptional: operating margin of 35.46% is 120.8% above the industrial machinery industry average of 16.07%, FCF of $363.75M nearly matches the $350.4M cash balance, and D/E of 0.50x is 40% below the industry average of 0.84x. However, forward EPS growth of 11.61% (next year) trails the industry average of 15.65% by 25.8%, and the 5-year EPS growth projection of 13.47% also lags peers at 14.91%. The news backdrop is strongly positive (90/100 sentiment): 2026 guidance raised to adjusted EPS of $6.55–$6.75 on revenue of $2.845–$2.875B, Q2 results beat expectations, and a bullish analyst initiation adds institutional credibility. The analyst consensus target of $243.11 implies 16.3% upside from current prices — materially better than the 9.1% upside in my prior report. The stock has now entered the lower bound of my prior entry range ($195–$210), making this a more actionable situation. HOLD with a conditional BUY trigger at $195–$210.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
68/100
Growth Potential
45/100
Valuation
35/100
Profitability
92/100
Debt Management
72/100
Analyst Sentiment
67/100
Technical Momentum
55/100
Insider Confidence
60/100
News Sentiment
85/100

Fundamental Analysis

CR's fundamentals present a classic quality-vs-valuation tension. Profitability is elite: gross margin 41.74% (vs. industry 36.67%, +13.8%), operating margin 35.46% (vs. industry 16.07%, +120.8%), net margin 12.97% (vs. industry 9.31%, +39.3%), ROE 16.54% (vs. industry 16.39%, essentially at parity but achieved with 40% less leverage). The 22.5 percentage point gap between operating margin (35.5%) and net margin (13.0%) reflects meaningful below-the-line charges — likely interest expense and tax burden — that compress reported earnings. FCF of $363.75M is robust and nearly equals the $350.4M cash balance, confirming real cash generation. D/E of 0.50x is conservative vs. the industry's 0.84x average. Growth is the weak link: forward EPS growth of 11.61% (next year) and 13.47% (5-year) both trail the industry averages of 15.65% and 14.91% respectively. Historical EPS growth of 10.6% is dramatically below the industry's 45.87%, though this partly reflects peers benefiting from larger cyclical recoveries. Revenue growth of 25.6% (vs. industry 11.57%) is impressive but has not translated to proportional earnings expansion. Valuation: P/E of 36.46x is a 23.1% discount to the industry average of 47.42x, but PEG of 1.99x is a 17.8% premium to the industry average of 1.69x — the critical disconnect. Investors pay less in absolute multiple terms but more per unit of growth. At current prices, the analyst consensus target of $243.11 implies 16.3% upside, improved from 9.1% in my prior report due to the 6.3% price decline.

News Sentiment

Crane Co. is firing on all cylinders operationally — but Wall Street is watching closely to see if the good times can last. The industrial manufacturer just delivered a standout second quarter, prompting management to raise its full-year 2026 guidance to adjusted earnings of $6.55 to $6.75 per share on revenue of $2.845 to $2.875 billion. That's the kind of confident outlook that gets investors' attention. The headline 'Crane Company Reports Second Quarter 2026 Results and Raises Full Year Adjusted EPS Guidance' tells the core story: this is a company executing at a high level, with management citing 'outstanding execution and momentum from recent acquisitions' as the engine driving outperformance. Earlier in the year, the company also raised guidance after Q1 results ('Crane Company Reports First Quarter 2026 Results and Raises Full Year EPS Guidance'), making back-to-back guidance increases a powerful signal of business momentum. Adding fuel to the bullish fire, a new analyst initiated coverage with a positive outlook ('This Crane Analyst Begins Coverage On A Bullish Note'), suggesting institutional investors are taking notice. The company was also highlighted among '3 Industrial Stocks Set to Beat Expectations This Earnings Season,' reflecting broader market confidence. The one wildcard: a leadership transition plan was announced, signaling planned executive succession. While orderly transitions are generally healthy, any management change introduces a degree of uncertainty. For everyday investors, the bottom line is simple — Crane is a well-run company delivering results, but the stock's premium price tag means you're paying up for that quality.

Risk Assessment

PRIMARY RISK: Valuation de-rating. At P/E 36.46x with 13.47% 5-year EPS growth (PEG 1.99x), any guidance miss on the raised 2026 EPS target of $6.55–$6.75 could trigger a 15–25% correction as the multiple compresses toward the industry average P/E of 47.42x (though CR's lower growth justifies a discount). SECONDARY RISK: Leadership transition. The announced executive succession plan introduces execution uncertainty — new management may alter capital allocation priorities or strategic direction. TERTIARY RISK: Revenue-to-earnings translation. Revenue growth of 25.6% dramatically outpacing earnings growth of 10.6% historically suggests margin compression or cost inflation that could worsen. MITIGATION: Stop-loss at $185 (11.5% below entry midpoint of $202.50) limits downside. The fortress balance sheet (D/E 0.50x, FCF $363.75M) provides a floor. Position sizing at 3.5% of portfolio limits concentration risk. The 16.3% upside to analyst consensus target ($243.11) and 30.1% to Target 2 ($263.42) provides adequate compensation for the risks at the $195–$210 entry zone.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is CR a halal stock?

Yes, Crane Company (CR) is halal-compliant per AAOIFI standards as of the latest quarterly review.

What is Plutrex's AI rating for CR?

Crane Company (CR) has a Plutrex AI rating of 64.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is CR a good investment?

According to Plutrex AI, CR has a Hold rating (64.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in CR?

US stocks like CR can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in CR?

Plutrex AI identifies the main risks for CR by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with Plutrex AI about CR

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open CR in Plutrex